FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/03/2025
Back to search
Official data from USPTO
LSL PHARMA DISTRIBUTION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
04/03/2026
Trademark type
Combined
Nice classes
35, 39
Filing date
05/24/2023
Registration date
02/25/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/25/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
25
Owner location
CH
Examiner
BROWNING, LUKE CASH
Law office
M80
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the blue wording "LSL", a blue shield with a white cross, and the wording "PHARMA DISTRIBUTION" in light gray.
Holders and representatives
Holders
R.G.C.C. Holdings AG
Representatives
James R. Menker Holley & Menker, PA
Technical classification
Nice Classes
Class 35Class 39
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Advertising services; commercial business management; commercial administration of the licensing of the goods and services of others; Providing office functions
Class 39
Transportin particular delivery of medicines in the framework of a mail-order pharmacy and in the framework of a pharmaceutical wholesale trade; packaging and storage of merchandise for others
Publications
History of USPTO decisions and trademark events.
27 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/11/2025
FIMP
FINAL DISPOSITION PROCESSED
09/11/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/25/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/19/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/31/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/31/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/25/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
02/25/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/07/2025
PUBO
PUBLISHED FOR OPPOSITION
01/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/21/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/21/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/21/2024
PETG
PETITION TO REVIVE-GRANTED
10/21/2024
PROA
TEAS PETITION TO REVIVE RECEIVED
10/21/2024
RFNT
REFUSAL PROCESSED BY IB
04/30/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/06/2024
RFRR
REFUSAL PROCESSED BY MPU
04/06/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/19/2024
CNRT
NON-FINAL ACTION WRITTEN
03/18/2024
DOCK
ASSIGNED TO EXAMINER
02/14/2024
MAFR
APPLICATION FILING RECEIPT MAILED
11/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/02/2023
Continuous trademark protection
Get notified about every new filing that threatens LSL PHARMA DISTRIBUTION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.